AGENDA: Randomised, double-blind trial of dacarbazine with or without Genasense® (oblimersen, G3139) in advanced melanoma

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2008
This article has no abstract
Epistemonikos ID: 5aa351f4ecba819ab6d81b7795643b0bc81d5a11
First added on: Jan 17, 2025